Only subtle trends emerged, including a slightly heavier body mass (p ≈ 0.055), a larger glycemic excursion after glucose load, a delayed return to normoglycemia, and higher fasting insulin levels at week 9, suggesting a modest predisposition to obesity and insulin resistance that remains effectively compensated during our project. This evidence concerns the gene INS and obesity disorder.